149 related articles for article (PubMed ID: 25945974)
1. Activity-Based Protein Profiling of Oncogene-Driven Changes in Metabolism Reveals Broad Dysregulation of PAFAH1B2 and 1B3 in Cancer.
Kohnz RA; Mulvihill MM; Chang JW; Hsu KL; Sorrentino A; Cravatt BF; Bandyopadhyay S; Goga A; Nomura DK
ACS Chem Biol; 2015 Jul; 10(7):1624-30. PubMed ID: 25945974
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibitor of platelet-activating factor acetylhydrolases 1b2 and 1b3 that impairs cancer cell survival.
Chang JW; Zuhl AM; Speers AE; Niessen S; Brown SJ; Mulvihill MM; Fan YC; Spicer TP; Southern M; Scampavia L; Fernandez-Vega V; Dix MM; Cameron MD; Hodder PS; Rosen H; Nomura DK; Kwon O; Hsu KL; Cravatt BF
ACS Chem Biol; 2015 Apr; 10(4):925-32. PubMed ID: 25602368
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity.
Mulvihill MM; Benjamin DI; Ji X; Le Scolan E; Louie SM; Shieh A; Green M; Narasimhalu T; Morris PJ; Luo K; Nomura DK
Chem Biol; 2014 Jul; 21(7):831-40. PubMed ID: 24954006
[TBL] [Abstract][Full Text] [Related]
4. Intracellular erythrocyte platelet-activating factor acetylhydrolase I inactivates aspirin in blood.
Zhou G; Marathe GK; Willard B; McIntyre TM
J Biol Chem; 2011 Oct; 286(40):34820-9. PubMed ID: 21844189
[TBL] [Abstract][Full Text] [Related]
5. Identification of selective covalent inhibitors of platelet activating factor acetylhydrolase 1B2 from the screening of an oxadiazolone-capped peptoid-azapeptoid hybrid library.
Sarma BK; Liu X; Kodadek T
Bioorg Med Chem; 2016 Sep; 24(17):3953-3963. PubMed ID: 27160052
[TBL] [Abstract][Full Text] [Related]
6. Aspirin hydrolysis in plasma is a variable function of butyrylcholinesterase and platelet-activating factor acetylhydrolase 1b2 (PAFAH1b2).
Zhou G; Marathe GK; Hartiala J; Hazen SL; Allayee H; Tang WH; McIntyre TM
J Biol Chem; 2013 Apr; 288(17):11940-8. PubMed ID: 23508960
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin G-induced malignant progression of MCF-7 cells involves suppression of PAF signaling through induced expression of PAFAH1B2.
Tanigawa K; Kiriya M; Hayashi Y; Shinden Y; Kijima Y; Natsugoe S; Sumimoto T; Morimoto-Kamata R; Yui S; Hama K; Yokoyama K; Nakamura Y; Suzuki K; Nojiri H; Inoue K; Karasawa K
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Aug; 1867(8):159164. PubMed ID: 35462067
[TBL] [Abstract][Full Text] [Related]
8. Novel isoforms of intracellular platelet activating factor acetylhydrolase (PAFAH1b2) in human testis; encoded by alternatively spliced mRNAs.
Scott BT; Olson N; Long GL; Bovill EG
Prostaglandins Other Lipid Mediat; 2008 Mar; 85(3-4):69-80. PubMed ID: 18155631
[TBL] [Abstract][Full Text] [Related]
9. Exclusion of the alpha2 subunit of platelet-activating factor acetylhydrolase 1b (PAFAH1B2) as a prothrombotic gene in a protein C-deficient kindred and population-based case-control sample.
Hasstedt SJ; Scott BT; Rosendaal FR; Callas PW; Vossen CY; Long GL; Bovill EG
Thromb Haemost; 2007 Sep; 98(3):587-92. PubMed ID: 17849047
[TBL] [Abstract][Full Text] [Related]
10. The Pafah1b complex interacts with the reelin receptor VLDLR.
Zhang G; Assadi AH; McNeil RS; Beffert U; Wynshaw-Boris A; Herz J; Clark GD; D'Arcangelo G
PLoS One; 2007 Feb; 2(2):e252. PubMed ID: 17330141
[TBL] [Abstract][Full Text] [Related]
11. Argininosuccinate Synthase 1 is a Metabolic Regulator of Colorectal Cancer Pathogenicity.
Bateman LA; Ku WM; Heslin MJ; Contreras CM; Skibola CF; Nomura DK
ACS Chem Biol; 2017 Apr; 12(4):905-911. PubMed ID: 28229591
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor acetylhydrolase: selective inhibition by potent n-alkyl methylphosphonofluoridates.
Quistad GB; Fisher KJ; Owen SC; Klintenberg R; Casida JE
Toxicol Appl Pharmacol; 2005 Jun; 205(2):149-56. PubMed ID: 15893542
[TBL] [Abstract][Full Text] [Related]
14. Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity.
Benjamin DI; Cozzo A; Ji X; Roberts LS; Louie SM; Mulvihill MM; Luo K; Nomura DK
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14912-7. PubMed ID: 23980144
[TBL] [Abstract][Full Text] [Related]
15. Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling.
Ng SB; Selvarajan V; Huang G; Zhou J; Feldman AL; Law M; Kwong YL; Shimizu N; Kagami Y; Aozasa K; Salto-Tellez M; Chng WJ
J Pathol; 2011 Mar; 223(4):496-510. PubMed ID: 21294123
[TBL] [Abstract][Full Text] [Related]
16. Previously uncharacterized roles of platelet-activating factor acetylhydrolase 1b complex in mouse spermatogenesis.
Yan W; Assadi AH; Wynshaw-Boris A; Eichele G; Matzuk MM; Clark GD
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7189-94. PubMed ID: 12775763
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers.
Imam JS; Buddavarapu K; Lee-Chang JS; Ganapathy S; Camosy C; Chen Y; Rao MK
Oncogene; 2010 Sep; 29(35):4971-9. PubMed ID: 20603620
[TBL] [Abstract][Full Text] [Related]
18. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
Menendez JA; Colomer R; Lupu R
Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of PAFAH1B1 is associated with tumor metastasis and poor survival in non-small cell lung cancer.
Lo FY; Chen HT; Cheng HC; Hsu HS; Wang YC
Lung Cancer; 2012 Sep; 77(3):585-92. PubMed ID: 22749159
[TBL] [Abstract][Full Text] [Related]
20. Microtubule-associated proteins as targets in cancer chemotherapy.
Bhat KM; Setaluri V
Clin Cancer Res; 2007 May; 13(10):2849-54. PubMed ID: 17504982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
